🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research study will investigate the safety and effectiveness of two di...
Status
Completed
Location
University of Southern Alabama Mitchell Cancer Institute
Start Date
2008-10
Trial ID
NCT00771810
This phase II trial studies how well therapeutic angiotensin-(1-7) works as...
Status
Completed
Location
Wake Forest University Health Sciences
Start Date
2009-10
Trial ID
NCT01553539
Treatments Being Tested
Phase 1, single-center, open-label, sequential cohort dose escalation study...
Status
Terminated
Location
MD Anderson Leukemia Department
Start Date
2011-04
Trial ID
NCT01362036
Treatments Being Tested
This is a 50-patient, Phase 2, double-blind, randomized, placebo-controlled...
Status
Unknown
Location
Sheba Medical Center
Start Date
2023-11-26
Trial ID
NCT06135103
Treatments Being Tested
The purpose of this study is to determine the safety and effectiveness of T...
Status
Terminated
Location
City of Hope Hospital
Start Date
2010-06
Trial ID
NCT01121120
This is a Phase I Study to be conducted in 18 healthy volunteers. Each will...
Status
Completed
Location
Charles River Clinical Servies Norhtwest
Start Date
2009-12
Trial ID
NCT01543971
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of TXA127 to reduce t...
Status
Withdrawn
Location
Winship Cancer Institute, Emory University
Start Date
2013-12
Trial ID
NCT01882387
Treatments Being Tested
Engraftment failure is a major obstacle to the success of cord blood transp...
Status
Withdrawn
Location
Pediatric Bone and Cord Blood, Duke Univ. Med. Center
Start Date
2012-03
Trial ID
NCT01554254
Treatments Being Tested
The purpose of this study is to evaluate the effect of TXA127 on neutrophil...
Status
Terminated
Location
MD Anderson Cancer Center
Start Date
2011-01
Trial ID
NCT01300611
Treatments Being Tested